Navigation Links
EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Date:8/19/2007

Third Phase II Trial Initiated by Myriad For Azixa(TM)

TARRYTOWN, N.Y., Aug. 17 /PRNewswire-FirstCall/ -- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today reported on new clinical advancements for Azixa(TM)* (MPC-6827), a vascular disrupting agent licensed by the Company to Myriad Genetics, Inc. as part of an exclusive, worldwide development and commercialization agreement.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO )

Myriad announced yesterday that it has initiated a third Phase II clinical trial for Azixa in patients with non-small-cell lung cancer that has spread to the brain. The trial is designed to assess Azixa's safety profile and the extent to which it can improve the overall survival of these patients. Two additional Phase II trials for Azixa are underway in primary brain cancer and melanoma that has spread to the brain.

"We are pleased at the clinical advancement Myriad has reported on Azixa, and view it as further evidence of the commercial potential of the compound," stated Jack Talley, President and Chief Executive Officer. "We believe that the study of Azixa in this new indication affords EpiCept with an expanded opportunity to capitalize on the financial benefits associated with our agreement with Myriad, including milestone payments, sublicensing income and potentially future royalties if Azixa continues to progress successfully."

Myriad is responsible for the worldwide development and commercialization of Azixa and any drug candidate that is developed from the series of compounds licensed by EpiCept to Myriad in 2003. The agreement requires that Myriad make future licensing, research and milestone payments to EpiCept, as well as pay a portion of any sublicensing income and pay a royalty on product sales. EpiCept will earn a milestone payment upon the dosing of the first patient in a Phas
'/>"/>

SOURCE EpiCept Corporation

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2008)... A key element of Carpenter,s EnviroSt...rade; Active Layer RS moisture barrier film is lam...t spills or liquids from soaking in. , ...008 -- DuPont today announced it has introduced D...isture barrier films for use in carpet cushioning....
(Date:12/3/2008)... and Europe Events Honor Customer Innovation and E...HOLMDEL, N.J., Dec. 3 /PRNewswire/ -- Sparta Sy... and compliance management software, today announ...nnection North American and European user events, ...the globe to discuss best practices for navigating...
(Date:12/3/2008)...el., Dec. 3 AstraZeneca ... Graham Baker as Vice President and Chief,Financi...Graham will be responsible for all Finance and Inf...tive January 1, 2009. He will be a member of,the... President, AstraZeneca,US. , In announcin...
(Date:12/3/2008)...NGS, Colo. and REYKJAVIK, Iceland, Dec. 3 /PRNewsw...e collaboration and implementation of,biorisk-fre...se in all HALO(R),Assay Kits and HALO(R) Contract...ood-forming cells is detected. , ORF Geneti...ytokines using,barley seed as the production host...
Breaking Biology Technology:DuPont Launches Innovative Renewably Sourced Material for Carpet Cushion 2DuPont Launches Innovative Renewably Sourced Material for Carpet Cushion 3DuPont Launches Innovative Renewably Sourced Material for Carpet Cushion 4Sparta Systems Demonstrates Global Enterprise Quality Management Leadership at TrackWise(R) Connection User Conferences 2Sparta Systems Demonstrates Global Enterprise Quality Management Leadership at TrackWise(R) Connection User Conferences 3AstraZeneca Appoints Graham Baker Vice President and Chief Financial Officer for North America 2HemoGenix(R), Inc Announces Implementation of ORF Genetics Human Growth Factors and Cytokines in All Human HALO(R) Assay Kits and Contract Research Services 2HemoGenix(R), Inc Announces Implementation of ORF Genetics Human Growth Factors and Cytokines in All Human HALO(R) Assay Kits and Contract Research Services 3
...inevicius, the first wave of streaming media was p... in sports and entertainment; but by and large, th...dia is now shifting from entertainment to being a ...nd the information experience. Just like the Inter...ons and educational institutions are beginning to ...
...aster recovery techniques, such as off-site tape r... full recovery, Ready Recovery provides nearly rea...tem mirroring technology, said Paul Shain, preside...-built products based on best practices gathered f...on can help organizations reduce complexity in the...
....S. Representative Tammy Baldwin (D-WI) has announ...ing as part of the fiscal budget to the UW-Rock Co...ed to upgrade computers and lab equipment for stud...nd other healthcare related fields. , ,I know that...ys economic development, Baldwin said. This school...
....S. Representative Tammy Baldwin and Wisconsin Gov...n companies will each receive federal grants of $2...d product development efforts. , ,Both based in Ma...ataGraft" skin tissue that could serve as syntheti...ogies that use non-flammable, renewable feed stock...
Other Biology Technology:Congresswoman Baldwin secures Federal Funds for UW-Rock County 2Stratatech and Virent Win $4M in U.S. Grants 2Stratatech and Virent Win $4M in U.S. Grants 3Stratatech and Virent Win $4M in U.S. Grants 4Stratatech and Virent Win $4M in U.S. Grants 5
(Date:12/2/2008)... Feeling threatened? Hungry? Looking for a mate? M...t easier to locate organisms and find out what the... are lacking. In a special feature on Movement Eco...cademy of Sciences , researchers present integrati...gut bacteria, tree seeds, ants, marine larvae and ...
(Date:12/2/2008)... This release is available in French . , P...iversity of California, Berkeley, have announced a...led epigenetics. They have demonstrated for the fi... silencing in plants. , The findings are import...lation in the continuing quest to breed enhanced c...
(Date:12/2/2008)..., With their sedentary lifestyles and filter-feed...e changes that humans have inflicted upon their wa... H. Carmichael of the Dauphin Island Sea Lab and h...in the prestigious journal Aquatic Biology . Usi...ted it is possible to identify and trace wastewate...
(Date:12/2/2008)... NEW BRUNSWICK, N.J. Rutgers, The State Universit...lion grant from the Robert Wood Johnson Foundation...d Health, on its George H. Cook Campus. , Rutgers...ntion to establish the new institute during his An...19. In that address, McCormick made it clear the n...
Breaking Biology News(10 mins):New movement models tested at the Smithsonian in Panama 2Plants display 'molecular amnesia' 2Plants display 'molecular amnesia' 3Rutgers receives US$10 million to establish Institute for Food, Nutrition and Health 2Defib Wire Warning Shouldnt Worry Most Users 3A Experts 3716 1Defib Wire Warning Shouldnt Worry Most Users 3A Experts 3716 2Defib Wire Warning Shouldnt Worry Most Users 3A Experts 3716 3Defib Wire Warning Shouldnt Worry Most Users 3A Experts 3716 4Baxter International Third Quarter 2007 Financial Results Conference Call 3712 1oh2 Medical Spa and Vein Removal Center Set to Open Doors in December 3708 1oh2 Medical Spa and Vein Removal Center Set to Open Doors in December 3708 2Greater China Corporation Forms TongRenTang Wellness Corporation 3704 1Greater China Corporation Forms TongRenTang Wellness Corporation 3704 2
...system cells can be genetically modified to brandi...ressively attack and kill leukemic cells. This fin...arch Hospital, suggests a way to improve the outco...phoblastic leukemia (ALL) or other blood cancers. ...the current online issue of Blood. , The researche...
...dren,s Research,Hospital have discovered that the ...teria helps these germs invade the human bloodstre...EMBO Journal, could help,scientists develop a vacc...ting children against the disease. The St. Jude re...like molecule that,Streptococcus pneumoniae bacter...
...on cancer cells spreading throughout the body, whi...e doctors a whole new weapon in the fight against ...ill Medical College of Cornell University research... analogues, prevented 91 to 99 percent of metastat...to target only metastatic cells. , "They,re unbel...
...y of Michigan,s,Comprehensive Cancer Center and th...that promote the growth and recurrence of skin can...logy in the U-M Medical,School, and colleagues at ... Institute examined the functions of the Hedgehog ...e most common form of cancer ?and,uncovered a subs...
Other Biology News:Genetically modified natural killer immune cells attack, kill leukemia cells 2New comparative toxicogenomics database 2New comparative toxicogenomics database 3First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers 2First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers 3U-M scientists find genes that control growth of common skin cancer 2U-M scientists find genes that control growth of common skin cancer 3
Monkey IL-2 ELISPOT Kit with white/opague microtiter plates
Human BMP 2 Construction Kit provides antigen affinity purified polyclonal capture and tracer antibodies, and antigen standard for development of approximately ten microplate assays.
...l ring small animal imaging PET system in the worl...utperfoms every competing systems in all performan...lution, timing resolution, and feature set., mic...ission Tomography) imaging device. microPET provid...
...gnificantly increase the shelf life of diluted per...at room temperature storage conditions in addition...0.45 micron filtration, and contains no mercury or...h levels of activity for both the enzyme and the a...
Biology Products: